BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28238617)

  • 1. Interaction Between Vitamin D and Lipoprotein (a) on the Presence and Extent of Coronary Heart Disease.
    Li K; Yang X; Wang L; Chen M; Xu L; Yang X
    Heart Lung Circ; 2017 Oct; 26(10):1079-1084. PubMed ID: 28238617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the association between smoking status and severity of coronary stenosis by vitamin D in patients suspected of coronary heart disease.
    Li K; Yang X; Wang L; Chen M; Zhao W; Xu L; Yang X
    Medicine (Baltimore); 2016 Sep; 95(36):e4817. PubMed ID: 27603397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A; Rothenbacher D; Khuseyinova N; Hoffmeister A; Maerz W; Nauck M; Scharnagl H; Koenig W; Brenner H
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect modification of hypertension on the association of vitamin D deficiency with severity of coronary stenosis.
    Li K; Zhao W; Wang L; Yang X; Yang X
    Blood Press; 2018 Jun; 27(3):134-140. PubMed ID: 29254371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoproteina(a) is a feature of the presence, diffuseness, and severity of coronary artery disease in Saudi population.
    Habib SS; Abdel-Gader AM; Kurdi MI; Al-Aseri Z; Soliman MM
    Saudi Med J; 2009 Mar; 30(3):346-52. PubMed ID: 19271061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study.
    Seman LJ; DeLuca C; Jenner JL; Cupples LA; McNamara JR; Wilson PW; Castelli WP; Ordovas JM; Schaefer EJ
    Clin Chem; 1999 Jul; 45(7):1039-46. PubMed ID: 10388480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study.
    Liu SL; Wu NQ; Guo YL; Zhu CG; Gao Y; Sun J; Xu RX; Liu G; Dong Q; Li JJ
    Postgrad Med J; 2019 Oct; 95(1128):534-540. PubMed ID: 31315919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
    Shai I; Rimm EB; Hankinson SE; Cannuscio C; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Eur Heart J; 2005 Aug; 26(16):1633-9. PubMed ID: 15824077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.
    Guan W; Cao J; Steffen BT; Post WS; Stein JH; Tattersall MC; Kaufman JD; McConnell JP; Hoefner DM; Warnick R; Tsai MY
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):996-1001. PubMed ID: 25810300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of lipoprotein(a) in pathogenesis of the high risk unstable angina].
    Yazici M; Demircan S; Ibrahimli F; Aksakal E; Sahin M; Sağkan O
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):13-7. PubMed ID: 16524794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
    Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
    Schaefer EJ; Lamon-Fava S; Jenner JL; McNamara JR; Ordovas JM; Davis CE; Abolafia JM; Lippel K; Levy RI
    JAMA; 1994 Apr; 271(13):999-1003. PubMed ID: 8139085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.
    Safarova MS; Ezhov MV; Afanasieva OI; Matchin YG; Atanesyan RV; Adamova IY; Utkina EA; Konovalov GA; Pokrovsky SN
    Atheroscler Suppl; 2013 Jan; 14(1):93-9. PubMed ID: 23357149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.